Poster Competition Winners
Congratulations to the following abstracts
Impact of positron emission tomography with 18F-fluciclovine on management of patients with suspected recurrence of prostate cancer: results from the LOCATE trial
Presenting Author: Karen Linder, PhD, Blue Earth Diagnostics
The role of multiparametric Magnetic Resonance Imaging (mpMRI) for different follow- up schemes in active surveillance of men with low-risk prostate cancer in the US: a cost-effectiveness modeling study
Presenting Author: Sejal Patel, MSc, Radboud University Medical Centre
Utility Of PSA Density In Predicting Upgraded Gleason Score In Men On Active Surveillance With
Presenting Author: Kamyar Ghabili Amirkhiz, MD, Yale School of Medicine
PI-RADS Trainer: An open-source prostate mpMRI web viewer and reporting platform for educational training
Presenting Author: Alireza Mehrtash, Brigham and Women’s Hospital, Harvard Medical School
The Third Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a unique multi-disciplinary forum organized to fill the currently existing gap between the key experts of in vivo imaging, the world authorities in the in vitro fluid- and tissue-based molecular diagnostics, including genomics, and thought leaders in the development of observation strategies (e.g., active surveillance) and novel therapeutic interventions.
For our outstanding speakers, please click here or download the Event Flyer.
Our goal is to inform the key health care stakeholders about the emerging advances in clinical case and research and create a consensus-based vision for the future of precision care and educational and research strategy for its realization. The Third Global Summit will build on the success of the First and Second Global Summits, which have emerged as the seminal events in recognizing radiogenomics – integrating imaging and molecular diagnostics – as the future of patient care. The specific aims of the program of the Third Summit include:
To expand the scope if the Summit to include both Precision Diagnostics and Treatment;
To expand a session on recurrent and advanced prostate cancer, including castrate-resistant metastasic disease;
To expand discussion on image-guided, minimally-invasive focal treatment and its clinical utility in localized and recurrent disease compared to other therapeutic interventions; and
To invite organizations leading accreditation, regulatory and reimbursement policies and stimulate discussion on creating a facilitated pathways for clinical validation and large-scale implementation of groundbreaking, high-quality, precision approaches to diagnostic and therapeutic interventions.
We would welcome sponsorship of the Third Global Summit on Precision Diagnosis for Prostate Cancer.
For our faculty members and speakers, please click here or download the Event Flyer.
Please see Sponsorship Levels (download here) and Sponsor Registration Form (download here).
Please also see Refund Policy for the Registration Fee.
If you have any questions and/or need more information regarding the planned Summit program or sponsorship, please contact Dr. Faina Shtern in our office by email (Faina.Shtern@admetechfoundation.org) or phone 617-523-3535.